The COVID-19 pandemic's ripple effects: investigating the impact of COVID-19 on endometrial cancer in a large UK regional cancer centre

COVID-19 has had a significant impact on the management of gynaecological malignancies globally. Despite the extensive work investigating the impact of the COVID-19 pandemic on gynaecological cancer care as a whole, little is known with regard to the specific management of endometrial cancer. The aim of this retrospective cohort study was to assess the impact of the COVID-19 pandemic on patients diagnosed with endometrial cancer in Northern Ireland (NI). All patients with endometrial cancer in NI between April 2019–March 2022 were included, divided into three cohorts: pre-COVID, COVID-Year 1 and COVID-Year 2. The median was used to express data that was not normally distributed. Students t-test and Mann-Whitney U test were used to compare means with and without normal distribution respectively. Statistical analysis of count data included the chi-squared test. The p-value < 0.05 was considered statistically significant. 683 patients were included with a similar distribution of age, histology and length of stay. There was a 22% decrease in new endometrial cancer diagnoses in COVID-Year 1 (n = 195) compared to Pre-COVID (n = 249), with evidence of recovery by year 2 (n = 241). In COVID-Year 1 there was a 29% decrease in surgical resections. During COVID-Year 2 there was an increase in symptom duration of >6 months (21%) compared to Pre-COVID (11% (p = 0.03)). By COVID-Year 2 there was an increase in Stage III disease (19%) compared to Pre-COVID (12% (p = 0.02)). In COVID-Year 1 and 2 there was an increase in the use of adjuvant oncological treatment, with a significant increase in the use of chemoradiotherapy in COVID-Year 2. In conclusion, COVID-19 has significantly impacted the treatment pathways of endometrial cancer patients in NI. There was a significant increase in symptom duration and stage III disease requiring increased use of adjuvant oncological treatments.

COVID-19 pandemic; Endometrial cancer; Surgical oncology; Adjuvant treatment

[1] Cancer Research UK. What is womb cancer? 2023. Available at: https://www.cancerresearchuk.org/about-cancer/womb-cancer/about (Accessed: 22 July 2023).

[2] Wylie J, Quinn D, Donnelly DW, McCluggage WG, Coleman HG, Gavin A, et al. The impact of the COVID-19 pandemic on endometrial cancer and endometrial hyperplasia diagnoses: a population-based study. American Journal of Obstetrics and Gynecology. 2022; 226: 737–739.e2.

[3] World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19—11 March 2020. 2020. Available at: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (Accessed: 22 July 2023).

[4] Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery. 2020; 76: 71–76.

[5] Royal College of Obstetricians and Gynaecologists. A prioritisation framework for care in response to COVID-19. Restoration and recovery: priorities for obstetrics and gynaecology. 2021. Available at: https://www.rcog.org.uk/media/heppbups/2021-04-20-restoration-and-recovery-priorities-for-obstetrics-and-gyn.pdf (Accessed: 9 October 2023).

[6] Thomas V, Maillard C, Barnard A, Snyman L, Chrysostomou A, Shimange-Matsose L, et al. International Society for Gynecologic Endoscopy (ISGE) guidelines and recommendations on gynecological endoscopy during the evolutionary phases of the SARS-CoV-2 pandemic. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2020; 253: 133–140.

[7] Royal College of Obstetricians and Gynaecologists. Joint RCOG, BSGE and BGCS guidance for the management of abnormal uterine bleeding in the evolving Coronavirus (COVID-19) pandemic. 2020. Available at: https://www.rcog.org.uk/media/oxyfyvy0/2020-05-21-joint-rcog-bsge-bgcs-guidance-for-management-of-abnormal-ute.pdf (Accessed: 09 October 2023).

[8] Gredmark T, Kvint S, Havel G, Mattsson L. Histopathological findings in women with postmenopausal bleeding. BJOG: An International Journal of Obstetrics & Gynaecology. 1995; 102: 133–136.

[9] Mowbray NG, Ansell J, Horwood J, Cornish J, Rizkallah P, Parker A, et al. Safe management of surgical smoke in the age of COVID-19. British Journal of Surgery. 2020; 107: 1406–1413.

[10] Manchanda R, Oxley S, Ghaem-Maghami S, Sundar S. COVID-19 and the impact on gynecologic cancer care. International Journal of Gynecology & Obstetrics. 2021; 155: 94–101.

[11] Oxley S, Kalra A, Sideris M, Itzkowitz N, Evans O, Atakpa EC, et al. Impact of multiple COVID-19 waves on gynaecological cancer services in the UK. Cancers. 2023; 15: 1273.

[12] Fotopoulou C, Khan T, Bracinik J, Glasbey J, Abu-Rustum N, Chiva L, et al. Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer Study. Obstetrical & Gynecological Survey. 2023; 78: 277–278.

[13] Cancer Research UK. Uterine cancer incidence statistics. 2023 Available at: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/uterine-cancer/incidence (Accessed: 30 October 2023).

[14] Local Government Association. Health inequalities: age and gender and COVID-19. 2023. Available at: https://www.local.gov.uk/age-and-gender-impact-covid-19# (Accessed: 30 October 2023).

[15] Vigezzi G Pietro, Bertuccio P, Amerio A, Bosetti C, Gori D, Cavalieri D’Oro L, et al. Older adults’ access to care during the COVID-19 pandemic: results from the lockdown and lifestyles (LOST) in Lombardia project. International Journal of Environmental Research and Public Health. 2022; 19: 11271.

[16] Gray DP, Sidaway-Lee K, Harding A, Evans P. Reduction in face-to-face GP consultations. British Journal of General Practice. 2020; 70: 328–328.

[17] Suh-Burgmann EJ, Alavi M, Schmittdiel J. Endometrial cancer detection during the coronavirus disease 2019 (COVID-19) pandemic. Obstetrics & Gynecology. 2020; 136: 842–843.

[18] Queen’s University Belfast. Further information Uterine cancer. 2023. Available at: www.qub.ac.uk/research-centres/nicr (Accessed: 22 July 2023).

[19] Royal College of Surgeons. Updated intercollegiate general surgery guidance on COVID-19. 2023. Available at: https://www.rcseng.ac.uk/coronavirus/joint-guidance-for-surgeons-v2/ (Accessed: 09 October 2023).

[20] Beamish AJ, Brown C, Abdelrahman T, Ryan Harper E, Harries Rl, Egan RJ, et al. International surgical guidance for COVID-19: validation using an international Delphi process-cross-sectional study. International Journal of Surgery. 2020; 79: 309–316.

[21] Lesley-Ann Black, Eileen Regan, Marta Cipriano. The unhealthy state of hospital waiting lists. 2021. Available at: http://www.niassembly.gov.uk/assembly-business/committees/2017-2022/health/research-papers-2021/the-unhealthy-state-of-hospital-waiting-lists/ (Accessed: 19 October 2023).